Miami, FL, United States of America

Eugene Ahn


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Hemostasis: The Contributions of Eugene Ahn

Introduction

Eugene Ahn is an innovative inventor based in Miami, FL, who has made significant contributions to the field of hemostasis. His work focuses on developing advanced solutions for controlling hemorrhage and treating bleeding disorders. With a keen interest in medical applications, Ahn has dedicated his research to improving patient outcomes in critical situations.

Latest Patents

Eugene Ahn holds a patent for "Cell-derived microparticles as hemostatic agents for control of hemorrhage and treatment of bleeding disorders." This patent encompasses compositions that include membrane-derived and synthetic microparticles designed to induce platelet aggregation. These microparticles are particularly useful for treating bleeding disorders, especially those involving platelet dysfunction. The microparticles consist of endothelial-derived microparticles (EMP), platelet-derived microparticles (PMP), erythrocyte-derived microparticles (RMP), and synthetic microparticles (SMP). They are specifically aimed at addressing disorders such as thrombocytopenia caused by chemotherapy.

Career Highlights

Ahn is affiliated with the University of Miami, where he continues to advance his research in the medical field. His work has garnered attention for its potential to revolutionize treatment methods for patients suffering from severe bleeding disorders. With a focus on practical applications, Ahn's innovations are paving the way for new therapeutic strategies.

Collaborations

Eugene Ahn collaborates with notable colleagues, including Wenche Jy and Joaquin J Jimenez. Their combined expertise enhances the research efforts at the University of Miami, fostering an environment of innovation and discovery.

Conclusion

Eugene Ahn's contributions to the field of hemostasis through his innovative patent demonstrate his commitment to improving medical treatments for bleeding disorders. His work not only highlights the importance of research in this area but also showcases the potential for future advancements in patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…